https://airnexis.com/
AirNexis | AirNexis Therapeutics Launches with $200M Series A
Jan 9, 2026 - AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
therapeuticslaunchesseries